» Articles » PMID: 31341699

Biliary Endoscopy in the Management of Primary Sclerosing Cholangitis and Its Complications

Overview
Journal Liver Res
Date 2019 Jul 26
PMID 31341699
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

Primary sclerosing cholangitis (PSC) is a chronic, idiopathic, cholestatic liver disease characterized by inflammation and fibrosis of the intrahepatic and/or extrahepatic bile ducts. It can affect individuals of all age groups and gender, has no established pharmacotherapy, and is associated with a variety of neoplastic ( cholangiocarcinoma) and non-neoplastic ( dominant strictures) hepatobiliary complications. Given these considerations, endoscopy plays a major role in the care of patients with PSC. In this review, we discuss and provide updates regarding endoscopic considerations in the management of hepatobiliary manifestations and complications of PSC. Where evidence is limited, we suggest pragmatic approaches based on currently available data and expert opinion.

Citing Articles

Preventive Antibiotic Use and Complications After Endoscopic Retrograde Cholangiopancreatography in Patients Hospitalized for Primary Sclerosing Cholangitis.

Uwumiro F, Anighoro S, Bojerenu M, Akpabio N, Asogwa S, Okpujie V Cureus. 2024; 16(7):e64429.

PMID: 39131042 PMC: 11317107. DOI: 10.7759/cureus.64429.


Clinical outcomes and reintervention after endoscopic retrograde cholangiopancreatography in primary sclerosing cholangitis in absence of cholangitis.

Horio R, Kato J, Taida T, Ohta Y, Saito K, Oyama Y Indian J Gastroenterol. 2024; 43(5):1021-1029.

PMID: 38995523 PMC: 11464613. DOI: 10.1007/s12664-024-01630-1.


Update on the optimisation of endoscopic retrograde cholangiography (ERC) in patients with primary sclerosing cholangitis.

Ahmed W, Joshi D, Huggett M, Everett S, James M, Menon S Frontline Gastroenterol. 2024; 15(1):74-83.

PMID: 38487565 PMC: 10935540. DOI: 10.1136/flgastro-2023-102491.


Primary Sclerosing Cholangitis-Associated Cholangiocarcinoma: From Pathogenesis to Diagnostic and Surveillance Strategies.

Catanzaro E, Gringeri E, Burra P, Gambato M Cancers (Basel). 2023; 15(20).

PMID: 37894314 PMC: 10604939. DOI: 10.3390/cancers15204947.


A comparison of balloon- versus stent-based approach for dominant strictures in primary sclerosing cholangitis: a meta-analysis.

Dhaliwal A, Naga Y, Ramai D, Saghir S, Daid S, Dhindsa B Ann Gastroenterol. 2022; 35(3):307-316.

PMID: 35599932 PMC: 9062839. DOI: 10.20524/aog.2022.0701.


References
1.
Hilscher M, Tabibian J, Carey E, Gostout C, Lindor K . Dominant strictures in primary sclerosing cholangitis: A multicenter survey of clinical definitions and practices. Hepatol Commun. 2018; 2(7):836-844. PMC: 6049068. DOI: 10.1002/hep4.1194. View

2.
Fang X, Zhang P . Aneuploidy and tumorigenesis. Semin Cell Dev Biol. 2011; 22(6):595-601. PMC: 3651908. DOI: 10.1016/j.semcdb.2011.03.002. View

3.
Tabibian J, Lindor K . Challenges of Cholangiocarcinoma Detection in Patients with Primary Sclerosing Cholangitis. J Anal Oncol. 2020; 1(1):50-55. PMC: 6939639. DOI: 10.6000/1927-7229.2012.01.01.7. View

4.
Gluck M, Cantone N, Brandabur J, Patterson D, Bredfeldt J, Kozarek R . A twenty-year experience with endoscopic therapy for symptomatic primary sclerosing cholangitis. J Clin Gastroenterol. 2008; 42(9):1032-9. DOI: 10.1097/MCG.0b013e3181646713. View

5.
Sun B, Hu B . The role of intraductal ultrasonography in pancreatobiliary diseases. Endosc Ultrasound. 2016; 5(5):291-299. PMC: 5070286. DOI: 10.4103/2303-9027.191607. View